February 9, 2022
EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immune Cell Therapies
BEIJING & SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies…